La activación de LXR/ApoE restringe la supresión inmune innata en el cáncer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Ver abstracta en PubMed
Resumen
Este resumen es generado por máquina.Dirigirse a las células supresoras derivadas de mieloides (MDSC) con agonistas del receptor hepático X (LXR) puede mejorar la inmunoterapia contra el cáncer. Este enfoque reduce las células inmunosupresoras, aumentando las respuestas de las células T antitumorales en modelos preclínicos y en un ensayo de fase 1.
Área De La Ciencia
- Inmunología
- En el campo de la oncología
- Farmacología
Sus Antecedentes
- La inmunoterapia contra el cáncer, en particular la inhibición del punto de control, ha revolucionado el tratamiento, pero se enfrenta a tasas de respuesta limitadas.
- Los que no responden a menudo presentan altos niveles de células supresoras inmunosupresoras derivadas de mieloides (MDSC).
Objetivo Del Estudio
- Identificar y dirigir las vías que regulan la abundancia de MDSC para mejorar la eficacia de la inmunoterapia contra el cáncer.
- Investigar el potencial terapéutico del agonismo del receptor nuclear del hígado-X (LXR) en la reducción de las MDSC y la mejora de la inmunidad antitumoral.
Principales Métodos
- Se utilizaron enfoques genéticos y farmacológicos para estudiar la regulación de la MDSC en modelos de cáncer murino.
- Se ha llevado a cabo un ensayo de fase 1 de aumento de la dosis en humanos de agonismo de la LXR en pacientes con cáncer.
- Se evaluaron los niveles de MDSC, las respuestas de los linfocitos T citotóxicos (CTL) y el papel de ApoE.
Principales Resultados
- El agonismo terapéutico de LXR redujo significativamente la abundancia de MDSC tanto en ratones como en pacientes humanos.
- El agotamiento de la MDSC se correlacionó con una mayor activación de la CTL en entornos preclínicos y clínicos.
- El objetivo LXR ApoE medió estos efectos, con la activación de LXR/ApoE promoviendo respuestas antitumorales y la activación de células T.
Conclusiones
- El eje LXR/ApoE es un regulador clave de la supresión inmune innata en el cáncer.
- Dirigirse a la vía LXR/ApoE representa una estrategia prometedora para mejorar la eficacia de la inmunoterapia contra el cáncer.
Contact us Si estos videos no son relevantes.
Contact us Si estos videos no son relevantes.
Videos de Conceptos Relacionados
The human immune system is a complex defense mechanism that protects the body from harmful pathogens and foreign substances. It comprises two crucial components: innate and adaptive immunity.
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Overview
The immune system comprises diverse biological structures and processes that protect the body from disease. These processes can be classified into innate and adaptive immunity. To work effectively, the immune system needs to detect pathogens by distinguishing the body’s own structures from foreign elements. If this determination fails, autoimmune diseases occur in which the immune system reacts against the body’s own tissue.
The Innate Immune System Acts Fast and...
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
Restriction enzymes are bacterial enzymes used to cut DNA in a sequence-specific manner. To cleave DNA, they bind to specific palindromic sequences called restriction sites. Such palindromic DNA sequences or inverted repeats are commonly found in regions of functional significance, such as the origin of replication, gene operator sites, and regions containing transcription termination signals.
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
Overview
The humoral immune response, also known as the antibody-mediated immune response, targets pathogens circulating in “humors,” or extracellular fluids, such as blood and lymph. Antibodies target invading pathogens for destruction via multiple defense mechanisms, including neutralization, opsonization, and activation of the complement system. Patients that are impaired in the production of antibodies suffer from severe and frequent infections by common pathogens and unusual...